Consensus Global Medical REIT Inc.

Equities

GMRE

US37954A2042

Market Closed - Nyse 16:00:02 2024-05-03 EDT 5-day change 1st Jan Change
8.4 USD +0.84% Intraday chart for Global Medical REIT Inc. +3.58% -24.32%

Evolution of the average Target Price on Global Medical REIT Inc.

Price target over the last 5 years

History of analyst recommendation changes

f7e82fcaf4c7.S_G5Ev1NgHjIOhK3gVnAbONr_W8SZiUdjzAQMnoMyNU.f6DVRY4D8RKNWWPirG6kFK5bqgNoEnN5615dWzJ4l48ihdx8siLoAJhbYQ~70d888d507f8132ca3499763a4fc21e5
B. Riley Trims Global Medical REIT's Price Target to $11 From $12 After Q1 Results Missed Expectations, Keeps Buy Rating MT
B. Riley Lowers Global Medical REIT's PT to $12 From $14, Reduce Near-Term Adjusted Funds From Operations Outlook; Keeps Buy Rating MT
B. Riley Lowers Global Medical REIT's Price Target to $12 From $14 After Q4 Results Missed Expectations, Keeps Buy Rating MT
B. Riley Lowers Global Medical REIT's PT to $14 From $16 as Economic Uncertainty, Interest Rates Stall Acquisition Activity; Keeps Buy Rating MT
Baird Downgrades Global Medical REIT to Neutral From Outperform MT
Janney Adjusts Fair Value Estimate on Global Medical REIT to $11 From $12, Says Neither Story Nor Balance Sheet 'Broken;' Buy Rating Kept MT
BMO Capital Downgrades Global Medical REIT to Market Perform From Outperform, Adjusts PT to $9 From $13 MT
Berenberg Bank Adjusts Global Medical REIT's Price Target to $15 From $18, Maintains Buy Rating MT
JMP Securities Initiates Coverage on Global Medical REIT With Market Perform Rating MT
BMO Capital Lowers Global Medical REIT's Price Target to $13 From $15.25, Outperform Rating Maintained MT
B. Riley Lowers Global Medical REIT's Price Target to $16 from $18 After Slight Q1 Miss on Higher Opex, Lower Occupancy; Keeps Buy Rating MT
Berenberg Bank Adjusts Global Medical REIT's Price Target to $18 From $19, Maintains Buy Rating MT
B. Riley Lowers Global Medical REIT's PT to $18 from $20, Notes Lower Occupancy, Higher Expenses, Lower Acquisition Cap Rate Assumptions; Keeps Buy Rating MT
KeyBanc Downgrades Global Medical REIT to Sector Weight From Overweight, Removes $17 Price Target MT
Janney Lifts Fair Value Estimate on Global Medical REIT to $20 From $18.50; Buy Rating Kept MT
B. Riley Lifts Global Medical REIT's PT to $20 from $18 on Higher Acquisition Expectations, Keeps Buy Rating MT
GLOBAL MEDICAL REIT : KeyBanc Starts Global Medical REIT at Overweight With $17 Price Target MT
GLOBAL MEDICAL REIT : Colliers Securities Starts Global Medical REIT at Buy With $18 Price Target MT
GLOBAL MEDICAL REIT : B. Riley Raises Global Medical REIT's PT to $18 from $16, Notes Well-Positioned Portfolio; Keeps Buy Rating MT
GLOBAL MEDICAL REIT : Baird Adjusts Global Medical REIT's Price Target to $17 from $15, Keeps Outperform Rating MT
GLOBAL MEDICAL REIT : Berenberg Bank Adjusts Price Target on Global Medical REIT to $18 From $17, Maintains Buy Rating MT
GLOBAL MEDICAL REIT : BMO Capital Starts Global Medical REIT at Outperform With $16 Price Target MT
GLOBAL MEDICAL REIT : Janney Adjusts Global Medical REIT's Fair Value Estimate to $15.50/Share From $15/Share, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
8.4 USD
Average target price
10.79 USD
Spread / Average Target
+28.47%
High Price Target
11.5 USD
Spread / Highest target
+36.90%
Low Price Target
10 USD
Spread / Lowest Target
+19.05%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Global Medical REIT Inc.

B. Riley
Baird
Janney Capital
BMO Capital
Berenberg Bank
JMP Securities
KeyBanc Capital Markets
Colliers Securities
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
  1. Stock Market
  2. Equities
  3. GMRE Stock
  4. Consensus Global Medical REIT Inc.